STXBP1 and Down syndrome: Thus, one of the approaches using ASOs as gene therapy for STXBP1 syndrome aims to elevate cellular levels of functional protein by ASOs competing with repressor miRNAs to bind mRNA sites and avoid its degradation, leading to higher levels of mature and functional mRNAs that could produce more protein.